Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
25
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Relapsing Refractory Diffuse Large Cell Lymphoma After Matched Unrelated Donor Bone Marrow Transplant with Immunosuppression Withdrawal and Rituximab

Raymond Wong Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Marcos de Lima Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Daniel Couriel Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Sergio Giralt Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Chitra Hosing Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Munir Shahjahan Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Yee Chung Cheng Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Jill Bruton Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
,
Richard Champlin Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
&
Issa Khouri Department of Blood and Marrow Transplantation, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, Houston, TX 77030-4009, USA
 show all
Pages 829-832 | Published online: 01 Jul 2009

  • Kolb, H.J., Schattenberg, A., Goldman, J.M., et al. (1995) "Graft-vercus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia", Blood 86(5), 2041-2050.
  • Collins, Jr. R.H., Shpilberg, O., Drobyski, W.R., et al. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after aIlogeneic bone marrow transplantation", J. Clin. Oncol. 15(2). 433-444.
  • Mackinnon, S., Papadopoulos, F.,B., Carahasi, M.H., et al. (1995) "Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease", Blood 86(4), 1261-1268.
  • van Besien, K.W., de Lima, M., Giralt, S.A., et al. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect", Bone Marrow Transplant 19(10), 977-982.
  • Horwitz, S.M., Negrin, R.S., Stockerl-Goldstein, K.E., et al. (2001) "Phase II trial of rituximab as adjuvant therapy to high dose chemotherapy and peripheral blood stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomas", Blood 98(11), 3578 (Abstract).
  • Khouri, I.E. Saliba, R.M., Giralt, S., et al. (2001) "Prolonged failure free survival and molecular responses with nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoina", Blood 98(11), 3098 (Abstract).
  • Milojkovic, D., Mijovic, A., Taylor, C.G., Mufti, G.J. and Pagliuca, A. (2000) "Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma", Br. J. Haematol. 110(4), 1013-1014.
  • O'Brien, S.M., Kantarjian, H., Thomas, D., et al. (2001) "Rituximab dose-escalation trial in chronic lymphocytic leukemia", J. Clin. Oncol. 19, 2165-2170.
  • Selenko, N., Majdic, O., Jager, L'., et al. (2002) "Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies?", J Clin Immunol. 22(3), 124-130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.